Parallax Volatility Advisers’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,181
Closed -$135K 3389
2020
Q3
$135K Sell
1,181
-56,376
-98% -$6.08M ﹤0.01% 2650
2020
Q2
$6.46M Buy
57,557
+10,585
+23% +$1.12M 0.09% 979
2020
Q1
$4.22M Buy
46,972
+38,092
+429% +$3.74M 0.04% 933
2019
Q4
$960K Buy
8,880
+3,723
+72% +$398K 0.01% 1537
2019
Q3
$505K Buy
+5,157
New +$581K 0.01% 1596
2019
Q2
Hold
0
4139
2019
Q1
Sell
-18,386
Closed -$2.29M 4441
2018
Q4
$1.79M Buy
+18,386
New +$2.17M 0.03% 1097
2018
Q3
Hold
0
4121
2018
Q2
Sell
-635
Closed -$71K 3873
2018
Q1
$71K Sell
635
-5,550
-90% -$663K ﹤0.01% 1429
2017
Q4
$740K Buy
+6,185
New +$753K 0.02% 1310
2017
Q3
Hold
0
3947
2017
Q2
Hold
0
4922
2017
Q1
Hold
0
5406
2016
Q3
Hold
0
4614
2016
Q2
Hold
0
4181
2016
Q1
Hold
0
4281
2015
Q4
Sell
-6,754
Closed -$1.18M 4416
2015
Q3
$1.06M Sell
6,754
-4,674
-41% -$853K 0.03% 1267
2015
Q2
$2.07M Buy
+11,428
New +$1.97M 0.06% 1054
2015
Q1
Sell
-2,664
Closed -$493K 5996
2014
Q4
$493K Buy
+2,664
New +$494K 0.02% 2063
2014
Q2
Sell
-39,789
Closed -$6.05M 4534
2014
Q1
$6.05M Buy
+39,789
New +$6.33M 0.34% 347

Other funds holding ALXN